Skip to main content
SpringerLink
Log in

Plasticity and the Spread of Alzheimer's Disease-Like Changes

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Tangles are a major histopathological feature of Alzheimer's disease and their regional location and number correlate significantly with the individual's cognitive decline. Intriguingly, these tangles are formed only in a small subset of nerve cell types and are practically absent in most animal species examined so far. In humans, tangle formation seemingly starts decades before clinical signs of dementia are seen and spread over cortical areas in a regular manner described by the Braak classification. In the present article the role of plasticity-related molecules and mechanisms are discussed considering their putative role in neuronal vulnerability and spread of tangles. Special emphasis is given to some aspects of lipid metabolism, that is, apolipoprotein E polymorphism, statin effects, and lysosomal dysfunction in Alzheimer's and Niemann-Pick C's diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Braak, H. and Braak, E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82:239-259.

    Google Scholar 

  2. Ghebremedhin, E., Schultz, C., Thal, D. R., Rüb, U., Ohm, T. G., Braak, E., and Braak, H. 2001. Gender and age modify the association between ApoE and AD-related neuropathology. Neurology 56:1696-1701.

    PubMed  Google Scholar 

  3. Ohm, T. G., Müller, H., Braak, H., and Bohl, J. 1995. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 64:209-217.

    PubMed  Google Scholar 

  4. Bancher, C., Braak, H., Fischer, P., and Jellinger, K. A. 1993. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci. Lett. 162:179-182.

    PubMed  Google Scholar 

  5. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., and Hyman, B. T. 1992. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42:631-639.

    PubMed  Google Scholar 

  6. Richard, S., Brion, J. P., Couck, A. M., and Flament-Durand, J. 1989. Accumulation of smooth endoplasmic reticulum in Alzheimers disease: New morphological evidence of axoplasmic flow disturbances. J. Submicrosc. Cytol. Pathol. 21:461-467.

    PubMed  Google Scholar 

  7. Bobinski, M., Wegiel, J., Tarnawski, M., de Leon, M. J., Reisberg, B., Miller, D. C., and Wisniewski, H. M. 1998. Duration of neurofibrillary changes in the hippocampal pyramidal neurons. Brain Res. 799:156-158.

    PubMed  Google Scholar 

  8. Morsch, R., Simon, W., and Coleman, P. D. 1999. Neurons may live for decades with neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 58:188-197.

    PubMed  Google Scholar 

  9. Braak, H., Braak, E., and Kalus, P. 1989. Alzheimer's disease: Areal and laminar pathology in the occipital isocortex. Acta Neuropathol. (Berl.) 77:494-506.

    Google Scholar 

  10. Braak, H. and Braak, E. 1990. Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia. Acta Neuropathol. (Berl.) 80:479-486.

    Google Scholar 

  11. Gomez Isla, T., Price, J. L., McKeel, D. W., Jr., Morris, J. C., Growdon, J. H., and Hyman, B. T. 1996. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:4491-4500.

    PubMed  Google Scholar 

  12. Schönheit, B., Zarski, R., and Ohm, T. G. 2003. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol. Aging (in press).

  13. Braak, H., Braak, E., Bohl, J., and Lang, W. 1989. Alzheimer's disease: Amyloid plaques in the cerebellum. J. Neurol. Sci. 93:277-287.

    PubMed  Google Scholar 

  14. Su, J. H., Deng, G., and Cotman, C. W. 1997. Transneuronal degeneration in the spread of Alzheimer's disease pathology: Immunohistochemical evidence for the transmission of tau hyperphosphorylation. Neurobiol. Dis. 4:365-375.

    PubMed  Google Scholar 

  15. Amaral, D. G. and Witter, M. P. 1989. The 3-dimensional organization of the hippocampal formation: A review of anatomical data. Neuroscience 31:571-591.

    PubMed  Google Scholar 

  16. Diekmann, S., Ohm, T. G., and Nitsch, R. 1996. Long-lasting transneuronal changes in rat dentate granule cell dendrites after entorhinal lesion: A combined intracellular injection and electron microscopic study. Brain Pathol. 6:205-215.

    PubMed  Google Scholar 

  17. Miehe, U., Leranth, C., Ohm, T. G., and Nitsch, R. 1994. Long-lasting transneuronal dendritic changes of GABAergic neurons in the monkey dentate gyrus following entorhinal cortex lesion. Neurosci. Lett. 168:115-118.

    PubMed  Google Scholar 

  18. Ohm, T. G., Münch, S., Schönheit, B., and Nitsch, R. 2002. Transneuronally altered dendritic processing of tangle-free neurons in Alzheimer's disease. Acta Neuropathol. (Berl.) 103:437-443.

    Google Scholar 

  19. Kohara, K., Kitamura, A., Morishima, M., and Tsumoto, T. 2001. Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons. Science 291:2419-2423.

    PubMed  Google Scholar 

  20. Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., and Crowther, R. 1989. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain. EMBO J. 8:393-399.

    PubMed  Google Scholar 

  21. Bu, B., Klunemann, H., Suzuku, K., Li, J., Bird, T., and Jin, L.-W., and Vincent, I. 2002. Niemann-Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles. Neurobiol. Dis. 11:285-297.

    PubMed  Google Scholar 

  22. Götz, J. 2001. Tau and transgenic animal models. Brain Res. Rev. 35:266-286.

    PubMed  Google Scholar 

  23. Vanier, M. T. and Suzuki, K. 1998. Recent advances in elucidating Niemann-Pick C disease. Brain Pathol. 8:163-174.

    PubMed  Google Scholar 

  24. Love, S., Bridges, L. R., and Case, C. P. 1995. Neurofibrillary tangles in Niemann-Pick disease type C. Brain 118:119-129.

    PubMed  Google Scholar 

  25. Horoupian, D. S. and Yang, S. S. 1978. Paired helical filaments in neurovisceral lipidosis (juvenile dystonic lipidosis). Ann. Neurol. 4:404-411.

    PubMed  Google Scholar 

  26. Auer, I. A., Schmidt, M. L., Lee, V. M., Curry, B., Suzuki, K., Shin, R. W., Pentchev, P. G., Carstea, E. D., and Trojanowski, J. Q. 1995. Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease. Acta Neuropathol. (Berl.) 90:547-551.

    Google Scholar 

  27. Suzuki, K., Parker, C. C., Pentchev, P. G., Katz, D., Ghetti, B., D'Agostino, A., and Carstea, E. D. 1995. Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol. (Berl.) 89:227-238.

    Google Scholar 

  28. Distl, R., Treiber-Held, S., Albert, F., Meske, V., Harzer, K., and Ohm, T. G. 2002. Cholesterol storage and tau-pathology in Niemann-Pick type C disease brain. J. Pathol. 200:704-777.

    Google Scholar 

  29. Carstea, E. D., Morris, J. A., Coleman, K. G., Loftus, S. K., Zhang, D., Cummings, C., Gu, J., Rosenfeld, M. A., Pavan, W. J., Krizman, D. B., Nagle, J., Polymeropoulos, M. H., Sturley, S. L., Ioannou, Y. A., Higgins, M. E., Comley, M., Cooney, A., Brown, A., Kaneski, C. R., Blanchette-Mackie, J., Dwyer, N. K., Neufeld, E. B., Chang, T.-Y., Liscum, L., Strauss III, J. F., Ohno, K., Zeigler, M., Carmi, R., Sokol, J., Markie, D., O'Neill, R. R., van Diggelen, O. P., Elleder, M., Patterson, M. C., Bradie, R. O., Vanier, M. T., Pentchev, P. G., and Tagle, D. A. 1997. Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis. Science 277:288-231.

    Google Scholar 

  30. Naureckiene, S., Sleat, D. E., Lackland, H., Fensom, A., Vanier, M. T., Wattiaux, R., Jadot, M., and Lobel, P. 2000. Identification of HE1 as the second gene of Niemann-Pick C disease. Science 290:2298-2301.

    PubMed  Google Scholar 

  31. Lange, Y., Ye, J., and Steck, T. L. 1998. Circulation of cholesterol between lysosomes and the plasma membrane. J. Biol. Chem. 273:18915-18922.

    PubMed  Google Scholar 

  32. Neufeld, E. B., Wastney, M., Patel, S., Suresh, S., Cooney, A. M., Dwyer, N. K., Roff, C. F., Ohno, K., Morris, J. A., Carstea, E. D., Incardona, J. P., Strauss, J. F. III., Vanier, M. T., Patterson, M. C., Brady, R. O., Pentchev, P. G., and Blanchette, M.-E. 1999. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J. Biol. Chem. 274:9627-9635.

    PubMed  Google Scholar 

  33. Zervas, M., Dobrenis, K., and Walkley, S. U. 2001. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J. Neuropathol. Exp. Neurol. 60:49-64.

    PubMed  Google Scholar 

  34. Distl, R., Meske, V., and Ohm, T. G. 2001. Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol. (Berl.) 101:547-554.

    Google Scholar 

  35. Ohm, T. G., Treiber-Held, S., Distl, R., Glöckner, F., Schönheit, B., and Tamannai, M., and Meske, V. 2003. Cholesterol and tau-protein: Findings in Alzheimer's and Niemann Pick C's disease. Pharmacopsychiatry (In press).

  36. Karten, B., Vance, D. E., Campenot, R. B., and and Vance, J. E. 2002. Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann-Pick C1-deficient neurons. J. Neurochem. 83:1154-1163.

    PubMed  Google Scholar 

  37. Xie, C., Burns, D. K., Turley, S. D., and Dietschy, J. M. 2000. Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased. J. Neuropathol. Exp. Neurol. 59:1106-1117.

    PubMed  Google Scholar 

  38. German, D. C., Quintero, E. M., Liang, C. L., Ng, B., Punia, S., Xie, C., and Dietschy, J. M. 2001. Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease. J. Comp. Neurol. 433:415-425.

    PubMed  Google Scholar 

  39. Sawamura, N., Gong, J. S., Garver, W. S., Heidenreich, R. A., Ninomiya, H., Ohno, K., Yanagisawa, K., and Michikawa, M. 2001. Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice. J. Biol. Chem. 276:10314-10319.

    PubMed  Google Scholar 

  40. Bu, B., Li, J., Davies, P., and Vincent, I. 2002. Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci. 22:6515-6525.

    PubMed  Google Scholar 

  41. Alonso, A., Zaidi, T., Novak, M., Grundke-Iqbal, I., and Iqbal, K. 2001. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. 98:6923-6928.

    PubMed  Google Scholar 

  42. Cedazo-Minguez, A., Hamker, U., Veh, R., Meske, V., Albert, F., Cowburn, R. F., and Ohm, T. G. 2001. Regulation of apolipoprotein E secretion in rat primary hippocampal astrocyte cultures. Neuroscience 105:651-661.

    PubMed  Google Scholar 

  43. Genis, L., Chen, Y., Shohami, E., and Michaelson, D. M. 2000. Tau hyperphosphorylation in apolipoprotein E-deficient and control mice after closed head injury. J. Neurosci. Res. 60:559-564.

    PubMed  Google Scholar 

  44. Bi, X., Yong, A. P., Zhou, J., Ribak, C. E., and Lynch, G. 2001. Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. 98:8832-8837.

    PubMed  Google Scholar 

  45. Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., Hulette, C., Crain, B., Goldgaber, D., and Roses, A. D. 1993. Association of apolipoprotein E allele epsilon-4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.

    PubMed  Google Scholar 

  46. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., Tanzi, R. E., Gusella, J. F., Small, G. W., Roses, A. D., Pericak Vance, M. A., and Haines, J. L. 1995. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 45:1323-1328.

    PubMed  Google Scholar 

  47. Ohm, T. G., Kirca, M., Bohl, J., Scharnagl, H., Gross, W., and März, W. 1995. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 66:583-587.

    PubMed  Google Scholar 

  48. Ohm, T. G., Scharnagl, H., März, W., and Bohl, J. 1999. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions. Acta Neuropathol. (Berl.) 98:273-280.

    Google Scholar 

  49. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, Jr., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., Tanzi, R. E., and et al. 1995. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 45:1323-1328.

    PubMed  Google Scholar 

  50. Poirier, J., May, P. C., Osterburg, H. H., Geddes, J., Cotman, C. W., and Finch, C. E. 1990. Selective alterations of RNA in rat hippocampus after entorhinal cortex lesioning. Proc. Nat. Acad. Sci. 87:303-307.

    PubMed  Google Scholar 

  51. Poirier, J. 1994. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:525-530.

    PubMed  Google Scholar 

  52. Poirier, J., Baccichet, A., Dea, D., and Gauthier, S. 1993. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55:81-90.

    PubMed  Google Scholar 

  53. Petegnief, V., Saura, J., Gregorio-Rocasolano, N., and Paul, S. M. 2001. Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: Nuclear factor kappaB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E. Neuroscience 104:223-234.

    PubMed  Google Scholar 

  54. Arendt, T., Brückner, M. K., Gertz, H. J., and Marcova, L. 1998. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience 83:991-1002.

    PubMed  Google Scholar 

  55. Arendt, T., Schindler, C., Brückner, M. K., Eschrich, K., Bigl, V., Zedlick, D., and Markova, L. 1997. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 allele. J. Neurosci. 17:516-529.

    PubMed  Google Scholar 

  56. Glöckner, F., Meske, V., and Ohm, T. G. 2002. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease. Neuroscience 114:1103-1114.

    PubMed  Google Scholar 

  57. Torack, R. M. and Miller, J. W. 1995. Denervation induced abnormal phosphorylation in hippocampal neurons. Brain Res. 669:135-139.

    PubMed  Google Scholar 

  58. Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., and Pitas, R. 1994. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850-852.

    PubMed  Google Scholar 

  59. Nathan, B. P., Jiang, Y., Wong, G. K., Shen, F., Brewer, G. J., and Struble, R. G. 2002. Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res. 928:96-105.

    PubMed  Google Scholar 

  60. Zetterberg, H., Palmer, M., Ricksten, A., Poirier, J., Palmqvist, L., Rymo, L., Zafiropoulos, A., Arvanitis, D. A., Spandidos, D. A., and Blennow, K. 2002. Influence of the apolipoprotein E epsilon4 allele on human embryonic development. Neurosci. Lett. 324:189-192.

    PubMed  Google Scholar 

  61. Yu, Y. W., Lin, C. H., Chen, S. P., Hong, C. J., and Tsai, S. J. 2000. Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neurosci. Lett. 294:179-181.

    PubMed  Google Scholar 

  62. White, F., Nicoll, J. A., Roses, A. D., and Horsburgh, K. 2001. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol. Dis. 8:611-625.

    PubMed  Google Scholar 

  63. Müller, W., Meske, V., Berlin, K., Scharnagl, H., März, W., and Ohm, T. G. 1998. Apolipoprotein E isoforms increase intracellular Ca2+ differentially through an omega-agatoxin IVa-sensitive Ca2+-channel. Brain Pathol. 8:641-653.

    PubMed  Google Scholar 

  64. Wisniewski, T., Castaño, E. M., Golabek, A., Vogel, T., and Frangione, B. 1994. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145:1030-1035.

    PubMed  Google Scholar 

  65. Barger, S. W. and Harmon, A. D. 1997. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388:878-881.

    PubMed  Google Scholar 

  66. Cullen, P., Cignarella, A., Brennhausen, B., Mohr, S., Assmann, G., and von Eckardstein, A. 1998. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. J. Clin. Invest. 101:1670-1677.

    PubMed  Google Scholar 

  67. Igbavboa, U., Avdulov, N. A., Schroeder, F., and Wood, W. G. 1996. Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice. J. Neurochem. 66:1717-1725.

    PubMed  Google Scholar 

  68. Göritz, C., Mauch, D. H., Nägler, K. and Pfrieger, F. W. 2002. Role of glia-derived cholesterol in synaptogenesis: New revelations in the synapse-glia affair. J. Physiol. Paris 96:257-263.

    PubMed  Google Scholar 

  69. Mitter, D., Reisinger, C., Hinz, H., Hollmann, S., Yelamanchili, S. V., Treiber-Held, S., Ohm, T. G., Herrmann, A., and Ahnert-Hilger, G. 2003. The synaptophysin/synaptobrevin interaction critically depends on the cholesterol content. J. Neurochem. 84:35-42.

    PubMed  Google Scholar 

  70. Meske, V., Albert, F., Richter, D., Schwarze, J., and Ohm, T. G. 2003. Blockade of HMG-CoA reductase activity causes changes in microtubule-stabilizing protein tau via suppression of geranyl-geranylpyrophosphate formation: Implications for Alzheimer's disease. Eur. J. Neurosci. 17:93-102.

    PubMed  Google Scholar 

  71. Dietschy, J. M. and Turley, S. D. 2001. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12:105-112.

    PubMed  Google Scholar 

  72. Braak, H. and Braak, E. 1996. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol. (Berl.) 92:197-201.

    Google Scholar 

  73. Fagan, A. M., Murphy, B. A., Patel, S. N., Kilbridge, J. F., Mobley, W. C., Bu, G., and Holtzman, D. M. 1998. Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (—/—) mice but impaired clearance of axonal degeneration products following injury. Exp. Neurol. 151:314-325.

    PubMed  Google Scholar 

  74. Gamblin, T. C., King, M. E., Koret, J., Berry, R. W., and Binder, L. I. 2001. Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry 39:14203-14210.

    Google Scholar 

  75. Davies, J. P. 2000. Transmembrane molecular pump activity of Niemann-Pick C1 protein. Science 290:2295-2298.

    PubMed  Google Scholar 

  76. Cataldo, A. M., Barnett, J. L., Berman, S. A., Li, J., Quarless, S., Bursztajn, S., Lippa, C., and Nixon, R. A. 1995. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14:671-680.

    PubMed  Google Scholar 

  77. Bednarski, E. and Lynch, G. 1996. Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. J. Neurochem. 67:1846-1855.

    PubMed  Google Scholar 

  78. Bednarski, E. and Lynch, G. 1998. Selective suppression of cathepsin L results from elevations in lysosomal pH and is followed by proteolysis of tau protein. Neuroreport 9:2089-2094.

    PubMed  Google Scholar 

  79. Bi, X., Zhou, J., and Lynch, G. 1999. Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease. Exp. Neurol. 158:312-327.

    PubMed  Google Scholar 

  80. Yamazaki, T., Chang, T. Y., Haass, C., and Ihara, Y. 2001. Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells. J. Biol. Chem. 276:4454-4460.

    PubMed  Google Scholar 

  81. Scharnagl, H., Tisljar, U., Winkler, K., Hüttinger, M., Nauck, M. A., Gross, W., Wieland, H., Ohm, T. G., and März, W. 1999. The A4 amyloid peptide enhances the uptake of beta-very low density lipoproteins by the low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor and heparan sulfate proteoglycans pathway. Lab. Invest. 79:1271-1286.

    PubMed  Google Scholar 

  82. Winkler, K., Scharnagl, H., Tisljar, U., Hoschutzky, H., Friedrich, I., Hoffmann, M. M., Hüttinger, M., Wieland, H., and März, W. 1999. Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis. J. Lipid Res. 40:447-455.

    PubMed  Google Scholar 

  83. Miklossy, J. and Van der Loos, H. 1987. Cholesterol ester crystals in polarized light show pathways in the human brain. Brain Res. 426:377-380.

    PubMed  Google Scholar 

  84. Yang, A. J., Chandswangbhuvana, D., Margol, L., and Glabe, C. G. 1998. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J. Neurosci. Res. 52:691-698.

    PubMed  Google Scholar 

  85. Ditaranto, K., Tekirian, T. L., and Yang, A. J. 2001. Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol. Dis. 8:19-31.

    PubMed  Google Scholar 

  86. Friedhoff, P., von Bergen, M., Mandelkow, E. M., Davies, P., and Mandelkow, E. 1998. A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc. Natl. Acad. Sci. 95:15712-15717.

    PubMed  Google Scholar 

  87. Braak, E., Braak, H., and Mandelkow, E. M. 1994. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. (Berl.) 87:554-567.

    Google Scholar 

  88. Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G. G., and Siegel, G. 2000. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57:1439-1443.

    PubMed  Google Scholar 

  89. Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S., and Drachman, D. A. 2000. Statins and the risk of dementia. Lancet 356:1627-1631.

    PubMed  Google Scholar 

  90. Wong, W. W., Dimitroulakos, J., Minden, M. D., and Penn, L. Z. 2002. HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 16:508-519.

    PubMed  Google Scholar 

  91. Naidu, A., Xu, Q., Catalano, R., and Cordell, B. 2002. Secretion of apolipoprotein E by brain glia requires protein prenylation and is suppressed by statins. Brain Res. 958:100-111.

    PubMed  Google Scholar 

  92. Hoyer, S. 2000. Brain glucose and energy metabolism abnormalitites in sporadic Alzheimer disease: Causes and consequences—an update. Exp. Gerontol. 35:1363-1372.

    PubMed  Google Scholar 

  93. Markesbery, W. R. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:134-147.

    PubMed  Google Scholar 

  94. Mandelkow, E. M. and Mandelkow, E. 1998. Tau in Alzheimer's disease. Trends Cell. Biol. 8:425-427.

    PubMed  Google Scholar 

  95. Hartmann, T. 2001. Cholesterol, A beta and Alzheimer's disease. Trends Neurosci. 24:S45-S48.

    PubMed  Google Scholar 

  96. Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., and Walsh, K. 2000. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat. Med. 6:1004-1010.

    PubMed  Google Scholar 

  97. Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J. P., and Anderton, B. H. 1992. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147:58-62.

    PubMed  Google Scholar 

  98. Lovestone, S. and Reynolds, C. H. 1997. The phosphorylation of tau: A critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78:309-324.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Anatomy, Department Clinical Cell and Neurobiology, Charité, Humboldt-University, 10098, Berlin, Germany

    Thomas G. Ohm

Authors
  1. Thomas G. Ohm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frauke Glöckner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roland Distl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stefanie Treiber-Held
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Volker Meske
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bärbel Schönheit
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas G. Ohm.

Additional information

Special issue dedicated to Dr. Carl Cotman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohm, T.G., Glöckner, F., Distl, R. et al. Plasticity and the Spread of Alzheimer's Disease-Like Changes. Neurochem Res 28, 1715–1723 (2003). https://doi.org/10.1023/A:1026017206925

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026017206925

Search

Navigation